We are monitoring the impact of COVID-19 on MEA Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 169
Share on
Share on

Middle East & Africa Biomarkers Market Research Report – Segmented By Product, Type, Disease Indications & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 169
Pages: 145

MEA Biomarkers Market Size (2021 to 2026)

The size of the biomarkers market in the Middle East & Africa region is expected to reach USD 7.98 billion by 2026 from USD 3.92 billion in 2021, growing at a CAGR of 15.29% during the forecast period.

Biomarkers are the biological molecules or genes that assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and are used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Thus, biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.

Rising demand for diagnostics, increasing biomarker research, growing awareness on biomarker applications, availability of large clinical samples for the testing laboratories, and increasing public & private organizations investment in biomarkers research are driving the growth of the biomarkers market in the Middle East & Africa.

However, the requirement of high capital investment and the high cost of biomarkers development are major factors restraining the growth of the biomarkers market in the Middle East & Africa.

This research report on the MEA Biomarkers Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Consumables
  • Software
  • Services

By Type: 

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers

By Application: 

  • Diagnostics Developments
  • Drug Discovery & Developments
  • Personalized Medicine
  • Disease Risk Assessment

By Disease Indications: 

  • Cancer
  • Cardiovascular
  • Neurological
  • Immunological Disorders

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

KEY MARKET PLAYERS:

A few of the prominent companies operating in the MEA Biomarkers Market profiled in this report are Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1          Product                                               

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

                                5.1.3 Software                                  

                                5.1.4 Services     Growth Hormone Therapy                         

                5.2          Type                                     

                                5.2.1 Introduction                                           

                                5.2.2 Safety Biomarkers                                               

                                5.2.3 Efficacy Biomarkers                                             

                                5.2.4 Validation Biomarkers                                        

                5.3          Application                                        

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostics Development                                 

                                5.3.3 Drug Discovery and Development                                

                                5.3.4 Personalised Medicine                                      

                                5.3.5 Disease Risk Assessment                                  

                                5.3.6 Other Applications                                               

                5.4          Disease Indications                                        

                                5.4.1 Introduction                                           

                                5.4.2 Cancer                                      

                                5.4.3 CardiovascularDisorders                                    

                                5.4.4 Neurological Disorders                                       

                                5.4.5 Immunological Disorders                                  

                                5.4.6 Other Diseases                                      

  1. Geographical Analysis

                6.1 Introduction                                                               

                6.2 Middle-East                                                                

                6.3 South Africa                                                               

                6.4 Rest of Middle East & Africa                                                

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 Bio-Rad Laboratories (U.S.)                                 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Qiagen N.V. (Netherlands)                                  

                8.3 Enzo Biochem (U.S.)                                               

                8.4 PerkinElmer, Inc. (U.S.)                                         

                8.5 Merck & Co, Inc. (U.S.)                                          

                8.6 EKF Diagnostics Holdings plc. (U.S.)                                  

                8.7 Meso Scale Diagnostics, LLC (U.S.)                                    

                8.8 Singulex, Inc. (U.S.)                                 

                8.9 BioSims Technologies (France)                                           

                8.10 Cisbio Bioassays (France)                                   

                8.11 Signosis, Inc. (U.S.)                                               

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Biomarkers Market By Region, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Biomarkers Market By Product, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Consumables Market By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Software Market By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Services Market By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Biomarkers Market By Type, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Safety Biomarkers Market By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Efficacy Biomarkers Market By Region, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Validation Biomarkers Market By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Biomarkers Market By Application, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Diagnostics Development Market By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Drug Discovery and Development Market By Region, From 2021 to 2026 (USD Million)
  13. Middle East & Africa Personalised Medicine Market By Region, From 2021 to 2026 (USD Million)
  14. Middle East & Africa Disease Risk Assessment Market By Region, From 2021 to 2026 (USD Million)
  15. Middle East & Africa Other Applications Market By Region, From 2021 to 2026 (USD Million)
  16. Middle East & Africa Biomarkers Market By Disease Indications, From 2021 to 2026 (USD Million)
  17. Middle East & Africa Cancer Market By Region, From 2021 to 2026 (USD Million)
  18. Middle East & Africa Cardiovascular Disorders Market By Region, From 2021 to 2026 (USD Million)
  19. Middle East & Africa Neurological Disorders Market By Region, From 2021 to 2026 (USD Million)
  20. Middle East & Africa Immunological Disorders Market By Region, From 2021 to 2026 (USD Million)
  21. Middle East & Africa Other Diseases Market By Region, From 2021 to 2026 (USD Million)
  22. Middle East Biomarkers Market By Product, From 2021 to 2026 (USD Million)
  23. Middle East Biomarkers Market By Type, From 2021 to 2026 (USD Million)
  24. Middle East Biomarkers Market By Application, From 2021 to 2026 (USD Million)
  25. Middle East Biomarkers Market By Disease Indications, From 2021 to 2026 (USD Million)
  26. South Africa Biomarkers Market By Product, From 2021 to 2026 (USD Million)
  27. South Africa Biomarkers Market By Type, From 2021 to 2026 (USD Million)
  28. South Africa Biomarkers Market By Application, From 2021 to 2026 (USD Million)
  29. South Africa Biomarkers Market By Disease Indications, From 2021 to 2026 (USD Million)
  30. Rest of Middle East & Africa Biomarkers Market By Product, From 2021 to 2026 (USD Million)
  31. Rest of Middle East & Africa Biomarkers Market By Type, From 2021 to 2026 (USD Million)
  32. Rest of Middle East & Africa Biomarkers Market By Application, From 2021 to 2026 (USD Million)
    1. Rest of Middle East & Africa Biomarkers Market By Disease Indications, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample